triciribine has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; He, D; Shen, J; Zhang, B | 1 |
| Habeck, K; Iskandar, F; Latsch, K; Mersmann, J; Tran, N; Zacharowski, K; Zimmermann, R | 1 |
2 other study(ies) available for triciribine and Reperfusion Injury
| Article | Year |
|---|---|
Inhaled Methane Protects Rats Against Neurological Dysfunction Induced by Cerebral Ischemia and Reperfusion Injury: PI3K/Akt/HO-1 Pathway Involved.
Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Brain Diseases; Brain Ischemia; Chromones; Disease Models, Animal; Enzyme Inhibitors; Heme Oxygenase-1; Male; Malondialdehyde; Methane; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Ribonucleosides; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice.
Topics: Androstadienes; Animals; Male; Mice; Myocardial Ischemia; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Ribonucleosides; Toll-Like Receptor 2; Wortmannin | 2012 |